Food Allergy Fund Microbiome Collective Grant

The Food Allergy Fund Microbiome Collective is inviting Letters of Intent for innovative research proposals aimed at understanding the microbiome's role in food allergies. This funding opportunity supports projects that explore immune interactions and seek prevention or treatment strategies for food-induced allergies and anaphylaxis. Grants, with suggested funding tiers of $75,000 to $250,000, will be awarded based on collaboration and innovation, fostering advancements in food allergy research.

Note: The deadline for submission of Letters of Intent is indicated above as the due date for Letters of Inquiry.
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF's grants support the creation of new treatments that will address the root causes of food allergies. Through our ground-breaking research and unique thought leadership summits, we accelerate innovation to find solutions.
Food Allergy Fund Request for Proposals
We’re committed to bridging the funding gap for scientific research into food allergies and are accepting Letters of Intent for three of our leading programs: The Microbiome Collective, the Drug Repurposing Program and Innovators Research Grants.
Grants will be awarded to research teams that propose innovative approaches to understanding the role that the microbiome plays in the development and persistence of food allergy. We would welcome proposals identifying investigations into the interaction between the mucosal surfaces and the immune system that result in the development of allergic responses to food. We also would be interested in approaches that would interrupt this process and could be useful for the prevention or treatment of food induced allergy and anaphylaxis.
Examples of relevant studies include those that define mechanisms of microbiome/immune interactions which produce food allergy and provide a scientific rationale use to understand this process. Also, we encourage work identifying methods of altering the microbiome environment to maintain food tolerance in previously allergic patients.
Examples could involve specific organisms or small molecules which can be used therapeutically to alter intestinal, mucosal or immune function.
Proposals will be reviewed and scored based on innovation and collaboration (across disciplines and/or institutions).Grant indirect costs are capped at 10%.
Suggested annual funding tiers are $75,000, $150,000, and $250,000. Requests outside these tiers will be considered on a case-by-case basis.
Grants may be awarded for terms of one or two years.

Eligibility

This RFP is open to academic investigators, university spinouts, and early-stage companies. Teams should have adequate pharmaceutical expertise or microbiome, genetic and human clinical trial expertise to document an eventual developmental approach for human use.